D50 Administration During Hemodialysis for Hypoglycemia
For hypoglycemic patients during hemodialysis, administer 10-25 grams of 50% dextrose (20-50 mL of D50) intravenously when capillary blood glucose (CBG) falls below 70 mg/dL, with a strong preference for titrated dosing using 5-gram aliquots to avoid overcorrection. 1, 2
Blood Glucose Threshold for Treatment
- Treat when CBG drops below 70 mg/dL (3.9 mmol/L) during hemodialysis, as this represents the standard threshold for hypoglycemia requiring intervention 3, 4
- Patients with pre-dialysis glucose levels below 140 mg/dL are at particularly high risk for intradialytic hypoglycemia and warrant closer monitoring 5
- Hypoglycemia during hemodialysis is frequently asymptomatic, occurring in up to 21% of diabetic patients on dialysis even with glucose-containing dialysate (100-150 mg/dL), making routine glucose monitoring essential 4
Dosing Strategy for D50
Initial Dose
- Administer 10-25 grams of dextrose as 50% solution (20-50 mL of D50) for insulin-induced or dialysis-related hypoglycemia 1
- The FDA-approved dosing for hypoglycemia treatment is 10-25 grams of dextrose given as 20-50 mL of 50% dextrose solution 1
Preferred Titrated Approach
- Use 5-gram aliquots (10 mL of D50) administered over 1 minute, repeated every minute as needed rather than giving the full 25-gram dose at once 2, 6
- This titrated approach corrects blood glucose into target range in 98% of patients within 30 minutes while avoiding overcorrection 2
- Median time to recovery of consciousness (GCS 15) is approximately 6-8 minutes regardless of concentration used 7, 6
- Titrated dosing with 5-gram aliquots results in lower total dextrose administration (median 10 grams vs 25 grams) and more appropriate post-treatment glucose levels 6
Maximum Dose
- Do not exceed 25 grams total in the initial treatment phase 1, 6
- Repeated doses and supportive treatment may be required in severe or refractory cases 1
Administration Technique
- Administer slowly via intravenous push to minimize complications 1
- Rapid administration of concentrated D50 has been associated with cardiac arrest and hyperkalemia 2
- Obtain blood glucose measurement before treatment when possible, but do not delay treatment in emergencies awaiting laboratory results 1
Monitoring Requirements
- Recheck CBG 15 minutes after each dose and repeat treatment if glucose remains below 70 mg/dL 3
- Continue monitoring every 15 minutes until blood glucose stabilizes above 70 mg/dL 3
- For patients on insulin infusions during dialysis, monitor glucose every 1-2 hours until stable, then every 4 hours 8
Hemodialysis-Specific Considerations
Risk Factors for Intradialytic Hypoglycemia
- Pre-dialysis glucose <140 mg/dL significantly increases hypoglycemia risk 5
- Use of glucose-free or low-glucose dialysate (<100 mg/dL) 5, 9
- Patients on insulin or sulfonylureas 10
- Impaired gluconeogenesis and reduced insulin clearance in advanced CKD 10
- Increased erythrocyte glucose uptake during hemodialysis 10
Prevention Strategies
- Patients with pre-dialysis glucose ≤100 mg/dL should be dialyzed with dialysate containing at least 100 mg/dL glucose 9
- Despite glucose-containing dialysate (100-150 mg/dL), sensor glucose may still fall below the dialysate concentration in 50% of patients 4
- Ensure patients do not skip meals before or during dialysis 9
Common Pitfalls to Avoid
- Avoid administering the full 25-gram dose as a single bolus, as this leads to excessive post-treatment hyperglycemia (median 169 mg/dL vs 112 mg/dL with titrated dosing) 2
- Do not rely on symptoms alone to detect hypoglycemia during hemodialysis—all hypoglycemic episodes may be asymptomatic due to blunted counterregulatory responses 9, 4
- Do not use point-of-care capillary glucose measurements without caution in dialysis patients; arterial blood glucose is preferred if arterial access is available 8
- Avoid using hypotonic solutions like D5W for volume replacement during dialysis, as these can worsen cerebral edema 11
Alternative Considerations
- While 10% dextrose in 5-gram aliquots (50 mL doses) is equally effective and results in lower post-treatment glucose levels, D50 remains the standard in most clinical settings due to smaller volume requirements 7, 6
- Glucagon is not recommended for dialysis patients due to delayed response (140 minutes to peak effect) and unpredictable efficacy in the setting of depleted glycogen stores 2